Hand in Hand. Psychological Support and Counseling to Breast Cancer Patients and Their Partners (HIH)

February 25, 2015 updated by: Anne Nicolaisen, University of Southern Denmark

Hand in Hand. Psychological Intervention for Breast Cancer Patients and Their Partners. A Randomised, Controlled Trial.

This study evaluates the effect of a psychological intervention to breast cancer patients and their partners compared to a control group receiving usual care

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The intervention intends to improving the patient and partners well-being, quality of life and their relationship adjustment.

The couples in the intervention group participates i six to eight couple sessions. The sessions is conducted by an experienced psychologist and takes place one to five months after the patients cancer diagnosis. The control group receives usual care.

The framework of the intervention is attachment theory and the psychologists support and advise the couples in talking candidly about their feelings regarding their new life situation with cancer. The psychologist focus on the couples ability to feel comfortable and safe in each others presence.

Study Type

Interventional

Enrollment (Actual)

198

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Denmark
      • Herlev, Denmark, 2730
        • Herlev University Hospital
      • Odense, Denmark, 5000
        • Odense University Hospital
      • Ringsted, Denmark, 4100
        • Ringsted Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women newly diagnosed with a primary breast cancer (in the last 4 weeks)
  • Women cohabiting with a male partner in a romantic relationship
  • Patient and partner speaks and reads danish

Exclusion Criteria:

  • Patients having a previous cancer diagnosis
  • Neoadjuvant therapy for breast cancer
  • Previous hospital admission with diagnosed psychotic episodes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual care
Experimental: Psychological Intervention
Behavioral: Psychological intervention
Couples in the intervention group attends six to eight couple-sessions performed by a psychologist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Impact of Event Scale (IES)
Time Frame: Baseline, 2 weeks post-intervention, 10 months follow-up
IES assesses traumatic reactions to the breast cancer diagnosis. Assessed by both patients and partners
Baseline, 2 weeks post-intervention, 10 months follow-up
Change in The Hospital Anxiety and Depression Scale (HADS)
Time Frame: Baseline, 2 weeks post-intervention, 10 months follow-up
Assesses feelings of anxiety and depressive symptoms. Assessed by both patients and partners.
Baseline, 2 weeks post-intervention, 10 months follow-up
Change in The Profile of Mood States - Short Form (POMS-SF)
Time Frame: Baseline, 2 weeks post-intervention, 10 months follow-up
Assesses mood changes. Assessed by both patients and partners
Baseline, 2 weeks post-intervention, 10 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Dyadic Adjustment Scale - Revised (DAS-R)
Time Frame: Baseline, 2 weeks post-intervention, 10 months follow-up
Assesses relationship functioning and marital satisfaction. Assesed by both patients and partners
Baseline, 2 weeks post-intervention, 10 months follow-up
Change in Relationship Questionnaire (RQ)
Time Frame: Baseline, 2 weeks post-intervention, 10 months follow-up
RQ provides a profile of an individual's attachment feelings and behaviour. Assessed by both patients and partners
Baseline, 2 weeks post-intervention, 10 months follow-up
Change in Functional Assessment of Cancer Therapy - Breast (FACT-B)
Time Frame: Baseline, 2 weeks post-intervention and 10 months follow-up
Assesses health-related quality of life with additional questions for women dignosed with breast cancer.
Baseline, 2 weeks post-intervention and 10 months follow-up
Change in Functional Assessment of Cancer Therapy - general population (FACT-GP)
Time Frame: Baseline, 2 weeks post-intervention and 10 months follow-up
Assesses health-related quality of life. Assessed by partners
Baseline, 2 weeks post-intervention and 10 months follow-up
Change in Functional Assessment of Chronic Illness Therapy-Fatigue
Time Frame: Baseline, 2 weeks post-intervention and 10 months follow-up
Assesses individual fellings of fatigue. Assessed by the patients
Baseline, 2 weeks post-intervention and 10 months follow-up
Change in Post Traumatic Growth Inventory
Time Frame: 2-weeks post-intervention and 10 months follow-up
Assesses positive changes in individuals experiencing traumatic life events. Assessed by both patients and partners
2-weeks post-intervention and 10 months follow-up
Change in EuroQol-5 Dimensions (EQ-5D)
Time Frame: Baseline, 2 weeks post-intervention and 10 months follow-up
Assesses health-related quality of life. Assessed by both patients and partners
Baseline, 2 weeks post-intervention and 10 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Southern Denmark

Collaborators

Odense University Hospital
University of Copenhagen
Danish Cancer Society
Region of Southern Denmark
Ringsted Hospital

Investigators

  • Principal Investigator: Dorte G Hansen, PhD, University of Southern Denmark
  • Study Chair: Mariët Hagedoorn, Professor, University of Groningen
  • Study Chair: Christoffer Johansen, Professor, Danish Cancer Society
  • Study Chair: Henrik Flyger, MD, Ph. D, University of Copenhagen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2011

Primary Completion (Actual)

August 1, 2013

Study Completion (Actual)

May 1, 2014

Study Registration Dates

First Submitted

May 23, 2011

First Submitted That Met QC Criteria

June 6, 2011

First Posted (Estimate)

June 7, 2011

Study Record Updates

Last Update Posted (Estimate)

February 26, 2015

Last Update Submitted That Met QC Criteria

February 25, 2015

Last Verified

February 1, 2015

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NFK-SDU-2011-5

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Psychological intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe